BridgeMD
New treatment option for Stuttering
Official title Exploring the Nature, Assessment and Treatment of Stuttering
ClinicalTrials.gov ID: NCT05908123
What this study is testing
- What it's testing
- The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 85. Healthy volunteers may be eligible.
You may be able to join if
- A participant will be considered a child who stutters (ages 2-17 years) if
- their parent/caregiver reports concern that their child is a person who stutters,
- they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions)...
- they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4). A participant will be considered an...
- they report they are a person who stutters,
You likely can't join if
- There are no exclusion criteria for persons who stutter.
See the full eligibility criteria
- A participant will be considered a child who stutters (ages 2-17 years) if
- their parent/caregiver reports concern that their child is a person who stutters,
- they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
- they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4). A participant will be considered an adult who stutters (18+ years) if
- they report they are a person who stutters,
- they have received a formal diagnosis of stuttering from a certified speech-language pathologist,
- they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
- they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4).
- There are no exclusion criteria for persons who stutter.
The study team makes the final eligibility decision.
Where it's taking place
- Austin, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Austin, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.